9150193

Source:http://linkedlifedata.com/resource/pubmed/id/9150193

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0008976, umls-concept:C0034656, umls-concept:C0039286, umls-concept:C0232970, umls-concept:C0439234, umls-concept:C1306673, umls-concept:C1522673
pubmed:issue	9
pubmed:dateCreated	1997-5-29
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9150193-8901852
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503089
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0027-8874
pubmed:author	pubmed-author:AndersenK WKW, pubmed-author:MachinDD
pubmed:issnType	Print
pubmed:day	7
pubmed:volume	89
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	659-60
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:9150193-Antineoplastic Agents, Hormonal, pubmed-meshheading:9150193-Breast Neoplasms, pubmed-meshheading:9150193-Female, pubmed-meshheading:9150193-Humans, pubmed-meshheading:9150193-Postmenopause, pubmed-meshheading:9150193-Tamoxifen, pubmed-meshheading:9150193-Time Factors, pubmed-meshheading:9150193-Treatment Outcome
pubmed:year	1997
pubmed:articleTitle	Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer.
pubmed:publicationType	Letter, Clinical Trial, Comment, Randomized Controlled Trial